Quarterly Results • Search Archive
Beta Drugs Limited
Results, Financials & Updates
Follow Beta Drugs Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.
2 published deep dives
2 quarters 1 sector
Company Overview
Beta Drugs Limited: latest results and financials
About the business in Nivata's latest coverage
Beta Drugs Limited operates as a specialized pharmaceutical company with a primary emphasis on oncology and assisted reproduction (IVF) therapeutics. The company researches, develops, manufactures, and markets high-end formulations and Active Pharmaceutical Ingredients (APIs). Commercial operations are anchored by manufacturing infrastructure centered in Baddi, Himachal Pradesh, encompassing facilities such as the Adley Formulation Plant. Its subsidiary network includes Adley Formulations Private Limited, Adley Lab Limited, Beta Research Private Limited, and Nivian Lifesciences Private Limited.
Quarter History
Beta Drugs reported trend
Each row comes from the corresponding Nivata Results brief. Reporting scope can differ between quarters; open the quarter for full context.
Quarter history
Beta Drugs Limited Results & Financials
Latest Nivata coverage: Q2 FY27 · revenue ₹137.49 Cr · PAT ₹19.28 Cr.
MainboardQ2 FY27
Beta Drugs Limited
Other IndustriesNSE: BETA · Consolidated
Revenue from operations · current quarter₹137.49 CrReported Q2 FY27 Profit after tax · current quarter₹19.28 CrReported Q2 FY27
Read the results deep dive ↗
MainboardQ1 FY27
Beta Drugs Limited
Other IndustriesNSE: BETA · Consolidated
Revenue growth (YoY)+25.2% EBITDA growth (YoY)+39.1%
Read the results deep dive ↗